The Pharma Latch Platform is purpose-built for the pharmaceutical industry, offering comprehensive support across your entire R&D process. From the Pharma Latch Pico, an adapted device for pre-clinical testing in small animals (rats/mice), to the Pharma Latch Hollow for HCP-administered clinical use in humans, and the Pharma Latch Self for patient self-administration, we are your partner throughout every stage of your intradermal journey.
The Pharma Latch Pico has been specially designed as a research tool for our pre-clinical partners who start their testing in small animals (mice/rats). The PLP is engineered to accommodate the highly elastic, thin skin of these animals. The device ensures accurate, consistent and complete dose delivery to the dermal layer – eliminating variability.
The Pharma Latch Hollow (PLH) is our first device built on our innovative platform. It is a healthcare professional administered, sterile, single-use medical device currently on the FDA 510(k) pathway for approval in the U.S.
The Pharma Latch Platform has been seamlessly integrated into a self-injection device tailored to meet the increasing demand for self-admin of drugs at home. The result is a user-friendly device that maintains precision while offering the convenience and simplicity required for personal use.
